A "Knife Fight" with the FDA: The Trump White House's Relentless Attacks on FDA's Coronavirus Response
Loading...
Serial Number
Levin Center Identifier
Document Date
2022-08-24
Report Length
69 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Report Type
Found Using Methodology
Yes
Committee(s)
Subcommittee(s)
Commission(s)
Idependent Author(s)
Brief Executive Summary
This report from the Select Subcommittee on the Coronavirus Crisis of the House Committee on Oversight and Reform is the second installment of findings from its investigation into the federal government's coronavirus pandemic response. The report focuses on three instances where Trump White House officials exerted coordinated pressure on the Food and Drug Administration (FDA) to align with political objectives. The report states the instances involve efforts to reauthorize hydroxychloroquine despite its ineffectiveness and potential danger, influence FDA's messaging on convalescent plasma before the 2020 Republican National Convention, and delay FDA guidance on coronavirus vaccine authorizations for political reasons.